Local Analgesia to Prevent Pain in Patient Undergoing Removal of the Uterus Through Vaginal Route
Status:
Completed
Trial end date:
2017-09-25
Target enrollment:
Participant gender:
Summary
Following a hysterectomy, women tend to experience high levels of pain, and many require
strong pain killers after the procedure. Ropivacaine is a local anaesthetic drug (injectable
numbing medication) which works by blocking pain signals. The aim of this study is to find
out whether injections of ropivacaine during surgery can help provide effective pain relief
after surgery.Women aged between 45 and 70 who are having a vaginal hysterectomy can
participate in the trial. Participants are randomly allocated to one of two groups. Those in
the first group are given injections of ropivacaine at the site of the wound and in the
peritoneum (space in the body that holds the organs in the abdomen) and those in the second
group are given injections of a saline fluid in the same places that offers no pain relief
before the end of their surgery. Participants in both groups are then regularly asked to rate
their pain levels up to 24 hours after surgery. In addition, the pain killers they receive
and length of hospital stay are recorded. There is a chance that the participants who receive
the ropivacaine will benefit from lower pain levels after surgery. There are no notable risks
of participating.